![](/img/cover-not-exists.png)
2030 ORAL Efficacy of neoadjuvant trastuzumab in patients with inflammatory breast cancer: data from the NOAH (NeOAdjuvant Herceptin) Phase III trial
J. Baselga, V. Semiglazov, G.M. Manikhas, W. Eiermann, A. Lluch, S. Tjulandin, A. Feyereislova, B. Vanhauwere, P. Valagussa, L. GianniVolume:
5
Year:
2007
Language:
english
DOI:
10.1016/s1359-6349(07)70792-9
File:
PDF, 60 KB
english, 2007